iN Therapeutics Co.,Ltd. announced that it has received KRW 26,000,000,000 in a bridge round of funding on February 7, 2022. The transaction included participation from new investors InterVest Co., Ltd., STIC Ventures, Inc., returning investors Yuanta Investment, Aju IB Investment Co., Ltd., Kiwoom Investment Co., Ltd., Timefolio Asset Management Co.,Ltd, Shinhan Capital, Investment Arm, DAYLI Partners Co., Ltd., and E& Venture Partners.